Febit Biotech this week launched its RT-Analyzer, a less-expensive benchtop version of its Geniom One platform that the company hopes will expand its installed base among array users both in its European home market as well as North America.
In addition, Febit plans to expand its presence in the catalog-array market. So far the company has offered its own microRNA biochips as catalog products. Now the company plans to debut 14 separate catalog arrays by this summer.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.